Oregon Cannabis: New Rules, Part 1

The coming New Year heralded new administrative regulations for marijuana in the State of Oregon. These changes came through the Oregon Liquor and Cannabis Commission (OLCC) rulemaking process. That process, in turn, stems from cannabis laws passed by the Oregon legislature earlier this year. We gave a brief overview of the new rules last week.

The post Oregon Cannabis: New Rules, Part 1 appeared first on Harris Bricken.

Read more
Filament Health Announces Health Canada Approval For Phase II Trial Administering New Psilocybin Microdose Formulation
Ryan Allway January 4th, 2022 Psychedelics The clinical trial at the University of Toronto will study low doses of psilocybin in healthy subjectswith persistent depressive disorder VANCOUVER, BC, Jan. 4, 2022 /CNW/ – Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (“Filament” or the “Company”), a clinical-stage natural psychedelic drug development company, today announced... Read more
YourWay Cannabis Brands Changes Symbol On OTC Markets
Ryan Allway January 4th, 2022 OTC Markets symbol change aligns with previously announced rebrand Company also announced application to up-list To OTCQB Venture Market VANCOUVER, BC, Jan. 4, 2022 /CNW/ – YourWay Cannabis Brands Inc. (CSE: YOUR) (OTC: YOURF) (FSE: HOB) (the “Company” or “YourWay“) today announced that the common shares... Read more
Item 9 Labs Corp. Enhances Board of Directors with Two Independent Appointments
Ryan Allway January 4th, 2022 Names Eric C. Kutscher and Lawrence X. Taylor to Board of Directors; Adds a Combined 55-Plus Years of Experience Across Patient-Centered Healthcare, Leadership, M&A and Strategic Planning PHOENIX, Jan. 4, 2022 /PRNewswire/ — Item 9 Labs Corp. (OTCQX: INLB) (the “Company”)—a vertically integrated cannabis dispensary franchisor and operator... Read more
MindMed Successfully Completes Phase 1 Clinical Trial of 18-MC
Ryan Allway January 4th, 2022 Psychedelics – Last subject completed study in late 2021 with topline results expected in early 2022 – – Results to inform design of Phase 2a study in individuals undergoing supervised opioid withdrawal – NEW YORK, Jan. 4, 2022 /CNW/ — Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED),... Read more
SciSparc Issued U.S. Patent For Its Core Technology That Treats Central Nervous Systems Disorders
Patent Extends Protection for its Novel Compounds and Methods Already granted in Australia and Japan TEL AVIV, Israel, Jan. 4, 2022 /PRNewswire/ — SciSparc Ltd. (NASDAQ: SPRC), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the “Company” or “SciSparc”), marks... Read more
CO gov issues mass marijuana pardon; Feds fund drug decrim & safe consumption research; Bizarre federal anti-cannabis PSA with cool cheetah Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Your... Read more
With a spike in robberies hitting marijuana businesses across the U.S., a leading cannabis advocacy group is providing the industry with resources on how to prevent and respond to theft. Americans for Safe Access (ASA) developed its Robbery Preparedness Guide in response to growing reports of targeted crime at... Read more
The incoming governor of Virginia says that while he’s not interested in re-criminalizing marijuana possession, which became legal in the state last summer, he feels there’s “still work to be done” before he gets behind creating a market for commercial sales and production. Advocates have been closely following Gov.-elect... Read more
Value, Growth and Opportunity: Why Psychedelic Stocks Are Poised To Rebound In 2022

After a tough year for stock performance in 2021, we lay out why the psychedelic drug industry is poised to bounce back strongly in 2022.

Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )